Wendeler M et al. |
The enzyme-binding region of human GM2-activator protein. |
2006 |
FEBS J. |
pmid:16478472
|
Kirvan CA et al. |
Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. |
2006 |
Autoimmunity |
pmid:16455579
|
Arfi A et al. |
Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta. |
2006 |
J. Neurochem. |
pmid:16441513
|
Ledeen RW and Wu G |
Gangliosides of the nuclear membrane: a crucial locus of cytoprotective modulation. |
2006 |
J. Cell. Biochem. |
pmid:16408301
|
Jacques S et al. |
Chemoenzymatic synthesis of GM3 and GM2 gangliosides containing a truncated ceramide functionalized for glycoconjugate synthesis and solid phase applications. |
2006 |
Org. Biomol. Chem. |
pmid:16358009
|
Sakuraba H et al. |
Molecular pathologies of and enzyme replacement therapies for lysosomal diseases. |
2006 |
CNS Neurol Disord Drug Targets |
pmid:16918392
|
Fuse T et al. |
Synthesis and enzymatic susceptibility of a series of novel GM2 analogs. |
2006 |
Glycoconj. J. |
pmid:16897176
|
Itakura T et al. |
Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice. |
2006 |
Biol. Pharm. Bull. |
pmid:16880605
|
Crawley AC et al. |
Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. |
2006 |
Brain Res. |
pmid:16828069
|
Biswas K et al. |
GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction. |
2006 |
Cancer Res. |
pmid:16818659
|
Thiesen PH et al. |
Glycolipids from a colloid chemical point of view. |
2006 |
J. Biotechnol. |
pmid:16707183
|
Bruce AF et al. |
Functional characterisation of a nematode secreted GM2-activator protein. |
2006 |
Mol. Biochem. Parasitol. |
pmid:16569450
|
Yin J et al. |
Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. |
2006 |
Cancer Res. |
pmid:16540641
|
Ragupathi G et al. |
Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates. |
2006 |
J. Am. Chem. Soc. |
pmid:16492059
|
Sango K et al. |
Impaired neurite outgrowth in the retina of a murine model of Sandhoff disease. |
2005 |
Invest. Ophthalmol. Vis. Sci. |
pmid:16123447
|
Tsuji D et al. |
Metabolic correction in microglia derived from Sandhoff disease model mice. |
2005 |
J. Neurochem. |
pmid:16092933
|
Schwarzmann G et al. |
Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system. |
2005 |
Glycobiology |
pmid:16079415
|
Retter MW et al. |
Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts. |
2005 |
Cancer Res. |
pmid:16024647
|
Blixt O et al. |
Chemoenzymatic synthesis of 2-azidoethyl-ganglio-oligosaccharides GD3, GT3, GM2, GD2, GT2, GM1, and GD1a. |
2005 |
Carbohydr. Res. |
pmid:16005859
|
Arfi A et al. |
Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts. |
2005 |
Neurobiol. Dis. |
pmid:15953731
|